Clinical testing and genomic insights have revolutionized the way disease is understood, which has enabled personalized treatment approaches that can be tailored to an individual’s unique genetic makeup. Harnessing the potential of genomic testing and its cutting-edge technology can significantly benefit patient outcomes. Read on to learn how BioReference® is supporting genomic testing and clinical […]
Search Results for: FORM
12
Feb
Feb
February is American Heart Month, a time to raise awareness about heart health and encourage everyone to take steps to prevent heart disease. At BioReference Health®, we are dedicated to supporting heart health and empowering individuals to prioritize their cardiovascular well-being. Through cutting-edge diagnostic testing, personalized wellness offerings, and educational resources, we are honored to […]
06
Feb
Feb
As we come together to recognize World Cancer Day in February 2024, it’s important to acknowledge the significant strides being made in cancer care. (123) BioReference continues to be at the forefront of these efforts, demonstrating a steadfast commitment to advancing oncology testing, tailored precision medicine, collaborative care and support, advancements in cancer research, and […]
25
Jan
Jan
As we enter January, the month dedicated to raising awareness about cervical cancer, it is crucial to emphasize the significance of early detection and prevention of this prevalent but preventable disease. (1,2,3,4,5) This Cervical Cancer Awareness Month, we are delighted to announce the collaborative efforts of BioReference Health and Teal Health in supporting a groundbreaking […]
Press Release
BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
28
Nov
Nov
Elmwood Park, NJ – November 28, 2023 – BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data (“RWD”) for the pharmaceutical and life science industries. This collaborative arrangement will offer healthcare providers and researchers unique solutions […]
27
Nov
Nov
Lung and bronchus cancer represents more than one eighth of all new cancer cases in the US and is the leading cause of cancer deaths worldwide, according to the World Health Organization. As we wrap up on National Lung Cancer Awareness Month this November, we aim to empower patients to take more control of their […]
17
Nov
Nov
For a wide range of industries and professionals involved in healthcare analytics, outcomes evaluation, patient care, or scientific research, harnessing the power of Real World Data (RWD) and accessing high-quality data carries immense benefits. Rich data is crucial for healthcare providers in order to make informed decisions that affect patient outcomes, and access to comprehensive […]
14
Nov
Nov
Grow it Out in Honor of Men’s Health throughout No Shave November, and talk to your healthcare provider about early detection screenings for Prostate Cancer like the 4Kscore Test from OPKO, BioReference and GenPath.
Press Release
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
07
Nov
Nov
World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON, MA, ELMWOOD PARK, NJ, and Rolle, Switzerland, November 7, 2023 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that […]
26
Oct
Oct
According to the National Down syndrome Society, in the US, 1 in 772 live births result in a Down syndrome diagnosis, making Down syndrome the most common chromosomal condition. The month of October is Down Syndrome Awareness Month, giving families, individuals, and patients the opportunity to share information about the condition, learn more, and contribute […]
